See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 21, 2003

Esophageal Cancer Urinary Incontinence Mantle Cell Lymphoma

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Esophageal Cancer

A research study of an investigational medication for patients with esophageal or stomach cancer. Volunteers 18 or older with histologically confirmed recurrent (inoperable) or metastatic adenocarcinoma of the esophagus, gastroesophageal junction, or stomach may be eligible. Research site located in Palm Springs, Florida.

More Information

Please see http://www.centerwatch.com/patient/studies/cat163.html.

-----

Urinary Incontinence

A research study of an investigational medication for urinary incontinence. Volunteers age 18 or older who have had urinary incontinence symptoms for at least three months, do not have a urinary tract infection, and have not recently been placed on a diuretic may be eligible. Research site located in Lafayette, Indiana.

More Information

Please see http://www.centerwatch.com/patient/studies/cat195.html.

-----

Mantle Cell Lymphoma

A research study of an investigational medication for relapsed or refractory mantle cell lymphoma. Volunteers age 18 or older who have documented relapsed or refractory mantle cell lymphoma following one or more prior therapies and who have adequate organ function may be eligible. Research site located in Birmingham, Alabama.

More Information

Please see http://www.centerwatch.com/patient/studies/cat628.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.